INmune Bio financial statements

인뮨 바이오NASDAQ:INMB · Nasdaq · Healthcare · sector #17
$1.87-3.61%
2026-10-06 close

INmune Bio's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$43M.

Reported results

INmune Bio notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q